Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Herrmann

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.
Journal of Medicinal Chemistry|October 28, 2005
First-in-class pan caspase inhibitor developed for the treatment of liver diseaseSteven D Linton, Teresa Aja, Robert A Armstrong, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.
Journal of Medicinal Chemistry|October 28, 2005
First-in-class pan caspase inhibitor developed for the treatment of liver diseaseSteven D Linton, Teresa Aja, Robert A Armstrong, et al.
Pageof 3